Using novel approaches to regulate cancer DNA for treatment of brain cancer and in breast cancer spread to the brain

Project title Using novel approaches to regulate cancer DNA for treatment of brain cancer and in breast cancer spread to the brain
Grant Amount
$446,227
Institution
University of Western Australia
Investigator Team
Principal investigators A/Prof. Pilar Blancafort, Prof. Anna Nowak, Dr. Raelene Endersby, A/Prof. Kerrie McDonald, Prof. Christobel Saunders, Prof. Melissa Davis, and Prof. Killugudi Swaminatha Iyer, with associate investigators Prof. Robyn Anderson, A/Prof. Andrew Redfern, Dr. Foteini Hassiotou, Dr. Joseph Cursons, and Dr. Alex Swarbrick
Grant Type
2019 Brain and Breast Collaborative Grant
Years
2019 – 2023

In 2019, Cure Brain Cancer Foundation and the National Breast Cancer Foundation came together to jointly fund high impact translational research that spans both primary brain cancer and breast cancers to improve survival for people diagnosed with these diseases.

The research team, led by A/Prof. Pilar Blancafort and Prof. Anna Nowak, will use gene-editing technology to turn off the MGMT gene in glioblastoma cells. High levels of this gene repair the damage caused by chemotherapy and radiotherapy. By switching the MGMT gene off, it is hoped this will enhance the ability of chemotherapy to destroy glioblastoma in the 60% of patients who have MGMT turned on and thus respond poorly to treatment. 

In breast cancer which has spread to the brain, we will use gene-editing technology to modulate genes which repair the DNA damage created by radiotherapy and other treatments, leading to treatment resistance.

“We have chosen to study breast cancer that has spread to the brain as well as brain cancer partly because both are treated with radiotherapy, which aims to damage the DNA of cancer cells…Our approach will hopefully enhance the standard treatment that is used for both cancers”

Prof. Anna Nowak